BIOMAT Database Logo BIOMAT Database Logo

Potent immunosuppressive effect of anti-LFA-1 monoclonal antibody on islet allograft rejection. 1995

M Nishihara, and M Gotoh, and T Fukuzaki, and Y Ohta, and M Monden, and H Yagita, and K Okumura, and M Miyasaka, and T Mori
Department of Surgery II, Osaka University Medical School, Japan.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

M Nishihara, and M Gotoh, and T Fukuzaki, and Y Ohta, and M Monden, and H Yagita, and K Okumura, and M Miyasaka, and T Mori
Preventing effect of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies on murine islet allograft rejection.
August 1999, International journal of pancreatology : official journal of the International Association of Pancreatology,
M Nishihara, and M Gotoh, and T Fukuzaki, and Y Ohta, and M Monden, and H Yagita, and K Okumura, and M Miyasaka, and T Mori
Potent ability of anti-LFA-1 monoclonal antibody to prolong allograft survival.
May 1984, Transplantation,
M Nishihara, and M Gotoh, and T Fukuzaki, and Y Ohta, and M Monden, and H Yagita, and K Okumura, and M Miyasaka, and T Mori
Induction of unresponsiveness to islet allograft by anti-LFA-1 monoclonal antibody treatment.
February 1993, Transplantation proceedings,
M Nishihara, and M Gotoh, and T Fukuzaki, and Y Ohta, and M Monden, and H Yagita, and K Okumura, and M Miyasaka, and T Mori
Anti-LFA-1 adhesion molecule monoclonal antibody in prophylaxis of human kidney allograft rejection.
February 1995, Transplantation proceedings,
M Nishihara, and M Gotoh, and T Fukuzaki, and Y Ohta, and M Monden, and H Yagita, and K Okumura, and M Miyasaka, and T Mori
Use of an anti-LFA-1 antibody in renal allograft rejection in sheep.
October 1992, Transplantation proceedings,
M Nishihara, and M Gotoh, and T Fukuzaki, and Y Ohta, and M Monden, and H Yagita, and K Okumura, and M Miyasaka, and T Mori
Effect of anti-LFA-1 monoclonal antibody on rat small bowel allograft survival and circulating leukocyte populations.
March 2000, Transplant immunology,
M Nishihara, and M Gotoh, and T Fukuzaki, and Y Ohta, and M Monden, and H Yagita, and K Okumura, and M Miyasaka, and T Mori
The effect of anti-interleukin-2 receptor monoclonal antibody on allograft rejection.
December 1985, Transplantation,
M Nishihara, and M Gotoh, and T Fukuzaki, and Y Ohta, and M Monden, and H Yagita, and K Okumura, and M Miyasaka, and T Mori
A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
January 1994, Transplantation,
M Nishihara, and M Gotoh, and T Fukuzaki, and Y Ohta, and M Monden, and H Yagita, and K Okumura, and M Miyasaka, and T Mori
Immunosuppressive effect of monoclonal antibodies to ICAM-1 and LFA-1 on peripheral nerve allograft in mice.
January 1995, Microsurgery,
M Nishihara, and M Gotoh, and T Fukuzaki, and Y Ohta, and M Monden, and H Yagita, and K Okumura, and M Miyasaka, and T Mori
Immunosuppression by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies of free and vascularized skin allograft rejection.
July 1996, Immunobiology,
Copied contents to your clipboard!